| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Diagnostic Radiology (N.A.C., N.J.P.), Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland 20892; Section on Endocrinology and Genetics (D.B., N.A.C., K.J.G., M.K., C.A.S.), Developmental Endocrinology Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892; Surgical Neurology Branch (E.H.O.), National Institute of Neurological Diseases and Stroke, Bethesda, Maryland 20892
Address all correspondence and requests for reprints to: Dr. Constantine A. Stratakis, Section on Endocrinology and Genetics, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Building 10, Room 10N262, 10 Center Drive, MSC 1862, Bethesda, Maryland 20892-1862. E-mail: stratakc{at}mail.nih.gov.
Context: We recently showed that pre- and postcontrast spoiled gradient-recalled acquisition in the steady-state (SPGR) was superior to conventional pre- and postcontrast T-1 weighted spin echo (SE) acquisition magnetic resonance imaging (MRI) for the diagnostic evaluation of pituitary tumors in adult patients.
Objective: The present investigation assessed the use of SPGR vs. SE-MRI in the diagnostic evaluation of ACTH-secreting tumors in children and adolescents with Cushing disease.
Design: Data were analyzed retrospectively from a series of patients seen over 7 yr (19972004).
Setting: The setting for this study was a tertiary care referral center.
Patients: Thirty children with Cushing disease (13 females and 17 males with a mean age of 12 ± 3 yr) were studied.
Interventions and Outcome Measures: Imaging results were compared with surgical and pathological findings and the clinical outcome.
Results: Twenty-eight patients had microadenomas, and two had macroadenomas; the latter were identified by both MRI techniques. Precontrast SE and SPGR-MRI identified four and six of the microadenomas, respectively. Postcontrast SPGR-MRI identified the location of the tumor in 18 of 28 patients, whereas postcontrast SE-MRI identified the location and accurately estimated the size of the tumor in only five patients (P < 0.001).
Conclusions: We conclude that conventional MRI, even with contrast enhancement, mostly failed to identify ACTH-secreting microadenomas in children and adolescents with Cushing disease. Postcontrast SPGR-MRI was superior to SE-MRI and should be used in addition to conventional SE-MRI in the pituitary evaluation of children and adolescents with suspected Cushing disease.
This article has been cited by other articles:
![]() |
P. Bougneres, L. Pantalone, A. Linglart, A. Rothenbuhler, and C. Le Stunff Endocrine Manifestations of the Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neural Tumor Syndrome in Childhood J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3971 - 3980. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Giri, D. L. Batista, B. P. Alter, and C. A. Stratakis Endocrine Abnormalities in Patients with Fanconi Anemia J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2624 - 2631. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Batista, M. Gennari, J. Riar, R. Chang, M. F. Keil, E. H. Oldfield, and C. A. Stratakis An Assessment of Petrosal Sinus Sampling for Localization of Pituitary Microadenomas in Children with Cushing Disease J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 221 - 224. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |